ADVANCED OVARIAN CANCER
Clinical trials for ADVANCED OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BMS-986500 enters first human trials for tough cancers
Disease control Recruiting nowThis early-stage study tests a new drug called BMS-986500 in people with advanced solid tumors or breast cancer that has stopped responding to standard treatments. The main goal is to check safety and find the right dose. About 234 adults will take part, receiving the drug alone …
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
New IgE antibody trial targets Hard-to-Treat ovarian and breast cancers
Disease control Recruiting nowThis early-phase trial tests an experimental drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have high levels of a protein called folate receptor alpha. The study has two parts: first, finding a safe dose, and then checki…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC